Feasibility and Tolerability of Lenvatinib, Plus PD-1 Blockades for Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study

Feasibility and Tolerability of Lenvatinib, Plus PD-1 Blockades for Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study

Meng Jia, Jiang-Kun Jia, Jian Xu, Huan-Zhou Xue Department of Hepatobiliary Surgery, Henan Provincial People’s Hospital, Zhengzhou, 450003, People’s Republic of ChinaCorrespondence: Huan-Zhou Xue, Department of Hepatobiliary Surgery of Henan Provincial People’s Hospital, No. 7 Wei-Wu Road, Zhengzhou...

Full description

Bibliographic Details
Main Authors: Jia M, Jia JK, Xu J, Xue HZ
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:Cancer Management and Research
Subjects:
hepatocellular carcinoma
lenvatinib
pd-1 blockades
efficacy
safety
Online Access:https://www.dovepress.com/feasibility-and-tolerability-of-lenvatinib-plus-pd-1-blockades-for-pat-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/feasibility-and-tolerability-of-lenvatinib-plus-pd-1-blockades-for-pat-peer-reviewed-fulltext-article-CMAR

Similar Items